3-iodobenzylguanidine has been researched along with Myopia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaturvedi, A; Franco, A; Katzman, PJ | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Myopia
Article | Year |
---|---|
Neonatal neuroblastoma 4s with diffuse liver metastases (Pepper syndrome) without an adrenal/extraadrenal primary identified on imaging.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Contrast Media; Developmental Disabilities; Diagnosis, Differential; Female; Fingers; Humans; Infant, Newborn; Intellectual Disability; Liver Neoplasms; Magnetic Resonance Imaging; Microcephaly; Muscle Hypotonia; Myopia; Neoplasm Staging; Neuroblastoma; Obesity; Organometallic Compounds; Retinal Degeneration; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2018 |